# SOLIGENIX, INC.: Form D filings

SOLIGENIX, INC., a pharmaceuticals company in Princeton, NJ, filed 7 Form D notices with the SEC between 2008 and 2017. The latest, on November 8, 2017, reports $2 million sold of a $2 million offering to 6 investors.

Find out what SOLIGENIX, INC. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20SOLIGENIX%2C%20INC.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=SOLIGENIX%2C%20INC.&page=%2Fdata%2Fform-d%2Fcompany%2Fsoligenix-inc-812796)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20SOLIGENIX%2C%20INC.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=SOLIGENIX%2C%20INC.&page=%2Fdata%2Fform-d%2Fcompany%2Fsoligenix-inc-812796)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in New Jersey](https://specstream.ai/data/form-d/state/new-jersey): 714 rows, by operating companies, filed since November 1, 2024, $35.70, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/new-jersey
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 29 EMMONS DRIVE, SUITE C-10, Princeton, NJ, 08540
- Phone: (609) 538-8200
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 812796

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Nov 8, 2017 | New notice | $1,964,000 | $1,964,000 | $0 | 6 | Nov 2, 2017 | [sec.gov](https://www.sec.gov/Archives/edgar/data/812796/000121390017011589/0001213900-17-011589-index.htm) |
| May 3, 2013 | New notice | $1,500,000 | $1,500,000 | $0 | 1 | Apr 27, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/812796/000081279613000001/0000812796-13-000001-index.htm) |
| Jul 2, 2010 | New notice | $5,904,277 | $5,904,277 | $0 | 46 | Jun 18, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/812796/000081279610000001/0000812796-10-000001-index.htm) |
| Mar 24, 2009 | New notice | $400,000 | $300,000 | $100,000 | 1 | Mar 6, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/812796/000081279609000013/0000812796-09-000013-index.htm) |
| Feb 27, 2009 | New notice | $4,500,000 | $4,500,000 | $0 | 1 | Feb 11, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/812796/000081279609000010/0000812796-09-000010-index.htm) |
| Feb 3, 2009 | New notice | $2,384,200 | $2,384,200 | $0 | 6 | Jan 20, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/812796/000081279609000005/0000812796-09-000005-index.htm) |
| Dec 5, 2008 | New notice | $1,500,000 | $1,500,000 | $0 | 1 | Dec 1, 2008 | [sec.gov](https://www.sec.gov/Archives/edgar/data/812796/000081279608000042/0000812796-08-000042-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Adam T. Rumage | Executive Officer |  |
| Richard C. Straube, MD MSc | Executive Officer |  |
| Karen Christopher Krumeich | Executive Officer |  |
| Oreola Christopher Donini, PhD | Executive Officer |  |
| Keith L. Brownlie, CPA | Director |  |
| Jerome B. Zeldis, PhD | Director |  |
| Gregg A. LaPointe, CPA | Director |  |
| Robert J. Rubin, MD | Director |  |
| R. Christopher Cavalli, PhD | Executive Officer |  |
| Marco M. Brughera, DVM | Director |  |
| Christopher J. Schaber, PhD | Executive Officer, Director |  |

## Other pharmaceuticals companies in New Jersey that filed recently

- [Grace Therapeutics, Inc.](https://specstream.ai/data/form-d/company/grace-therapeutics-inc-1444192) $10 million · Aug 11, 2026

[Every Form D from the week of Nov 6, 2017](https://specstream.ai/data/form-d/week/2017-11-06) · [All recent filings in New Jersey](https://specstream.ai/data/form-d/state/new-jersey) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what SOLIGENIX, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).